PERRIGO Co plc — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 42/100
What the filing says
Perrigo reported Q2 2026 net sales of $1,023M (down 3.2% YoY); Core adjusted EPS fell 20.7% to $0.46. The company completed the Dermacosmetics divestiture, generating $359M in cash proceeds applied to debt reduction (debt fell from $3,603.6M to $3,283.4M). Gross margins compressed 250 bps on volume declines and planned under-absorption. The company reaffirmed full-year 2026 guidance with expected H2 improvement from moderation of prior-year underabsorption and favorable comparisons.
Why this rating
Organic sales decline and EPS drop are real operational headwinds. Divestiture + debt reduction are positive actions, but relative to $3.7B market cap, Q2 results show business contraction, not material transformation.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.